RT Journal Article
SR Electronic
T1 Monkeypox in the New York metropolitan area, Summer 2022
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.24.22282177
DO 10.1101/2022.11.24.22282177
A1 Gnanaprakasam, Rachel
A1 Keller, Marina
A1 Glassman, Rebecca
A1 El Khoury, Marc Y
A1 Chen, Donald
A1 Feola, Nicholas
A1 Feldman, Jared
A1 Chaturvedi, Vishnu
YR 2022
UL http://medrxiv.org/content/early/2022/11/27/2022.11.24.22282177.abstract
AB Early in the 2022 Monkeypox global outbreak, caseloads in the New York metropolitan area climbed rapidly before other US urban areas. We summarize our monkeypox clinical experience detecting, treating, and vaccinating during a quickly evolving emerging infection.Ethical statement Institutional Review Board exemption was granted for this study.Funding statement No funding was obtainedConflict of interest NoneAuthors’ contributions Each author actively participated in data collection, analysis and editing of the manuscript.Collaborators NoneCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:New York Medical College General Medical and Behavioral Instiutional Review Board gave Westchester Medical Center gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors